EPIGRAL vs SHK: Stock Comparison
Epigral Limited vs S H Kelkar and Company Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Epigral Limited is the larger company by market capitalisation. Epigral Limited shows a lower P/E, a higher ROE and faster revenue growth, while S H Kelkar and Company Limited shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Epigral Limited and S H Kelkar and Company Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | EPIGRAL | SHK |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | EPIGRAL | SHK |
|---|---|---|
| Live Price | ₹1,162.7 | ₹140.65 |
| Day Change | 0.93% | 0.05% |
| Volume | 3.02 L | 2.17 L |
| 52-Week High | ₹2,114 | ₹275.5 |
| 52-Week Low | ₹807 | ₹111.98 |
| Distance from 52W High | -45% | -48.95% |
Valuation
| Metric | EPIGRAL | SHK |
|---|---|---|
| Market Cap | ₹5,036 Cr | ₹1,932 Cr |
| P/E Ratio | 15.04x | 28.31x |
| P/B Ratio | 2.25x | 1.44x |
| EPS | ₹75.27 | ₹5.01 |
| Book Value | ₹514.92 | ₹95.7 |
| Dividend Yield | 0.43% | 1.54% |
Growth
| Metric | EPIGRAL | SHK |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.3% | 13.8% |
| EPS Growth (TTM YoY) | -6.8% | -98.2% |
| Qtr Sales Growth | 17.3% | 14.6% |
| Qtr Profit Growth | -6.84% | -96.2% |
Profitability & Leverage
| Metric | EPIGRAL | SHK |
|---|---|---|
| ROE | 16% | 3.71% |
| ROCE | 15.5% | 5.85% |
| Net Margin | 13.14% | 2.94% |
| Operating Margin | 22.4% | 10.2% |
| Debt to Equity | 0.26x | 0.76x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | EPIGRAL | SHK |
|---|---|---|
| Promoter Holding | 68.83% | 43.4% |
| FII Holding | 1.03%▼ 0.51 pp | 5.92%▼ 1.5 pp |
| DII Holding | 5.56%▲ 0.66 pp | 6.01%▲ 0.83 pp |
| Public Holding | 24.55%▼ 0.15 pp | 33.21%▲ 0.68 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Epigral Limited and S H Kelkar and Company Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.